Published in Clin Infect Dis on September 11, 2007
Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med (2012) 3.79
Clinical practice. Lyme disease. N Engl J Med (2014) 2.63
A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis. PLoS Negl Trop Dis (2008) 1.05
Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR. PLoS One (2013) 1.02
Epidemiological situation of Lyme borreliosis in Belgium, 2003 to 2012. Arch Public Health (2015) 0.98
Variable VlsE is critical for host reinfection by the Lyme disease spirochete. PLoS One (2013) 0.96
Lyme disease. N Engl J Med (2014) 0.88
Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States. Emerg Infect Dis (2016) 0.85
Reinfection versus relapse in patients with lyme disease: not enough evidence. Clin Infect Dis (2008) 0.84
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato. Clin Vaccine Immunol (2014) 0.78
Public health impact of strain specific immunity to Borrelia burgdorferi. BMC Infect Dis (2015) 0.78
How do biting disease vectors behaviourally respond to host availability? Parasit Vectors (2016) 0.76
Evaluation of the Importance of VlsE Antigenic Variation for the Enzootic Cycle of Borrelia burgdorferi. PLoS One (2015) 0.76
Diagnostic pitfalls in a young Romanian ranger with an acute psychotic episode. Neuropsychiatr Dis Treat (2016) 0.75
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
Lyme borreliosis. Lancet (2011) 4.81
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med (2012) 3.79
Subjective symptoms after treatment of early Lyme disease. Am J Med (2010) 3.22
Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis (2003) 3.18
Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis (2011) 2.88
Common misconceptions about Lyme disease. Am J Med (2013) 2.84
Treatment trials for post-Lyme disease symptoms revisited. Am J Med (2013) 2.75
MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. Proc Natl Acad Sci U S A (2008) 2.67
Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun (2010) 2.50
Southern Tick-Associated Rash Illness (STARI) in the North: STARI following a tick bite in Long Island, New York. Clin Infect Dis (2011) 2.19
Human Borrelia miyamotoi infection in the United States. N Engl J Med (2013) 2.11
Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis (2002) 1.97
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg (2008) 1.82
Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother (2010) 1.75
Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis (2008) 1.71
Serologic markers of Lyme disease in children with autism. JAMA (2013) 1.67
Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med (2003) 1.62
Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study. Vector Borne Zoonotic Dis (2013) 1.59
Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med (2012) 1.50
Single-dose prophylaxis against Lyme disease. Lancet Infect Dis (2007) 1.45
Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol (2002) 1.45
Poly-ticks: Blue State versus Red State for Lyme disease. Lancet (2005) 1.42
Why has Borrelia burgdorferi not been transmitted by blood transfusion? Transfusion (2013) 1.42
Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol (2002) 1.40
Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J Bacteriol (2006) 1.34
Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med (2007) 1.29
Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis (2011) 1.24
Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol (2003) 1.24
Improving the yield of blood cultures from patients with early Lyme disease. J Clin Microbiol (2011) 1.22
Bartonella spp. transmission by ticks not established. Emerg Infect Dis (2010) 1.19
Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome. Clin Immunol (2011) 1.18
Borrelia burgdorferi sensu stricto is clonal in patients with early Lyme borreliosis. Appl Environ Microbiol (2008) 1.16
2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test. Clin Infect Dis (2010) 1.15
Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States. Emerg Infect Dis (2014) 1.13
Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol (2002) 1.11
A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr (2005) 1.10
Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease. Diagn Microbiol Infect Dis (2012) 1.10
Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome. Clin Vaccine Immunol (2011) 1.09
Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates. Infect Immun (2004) 1.08
MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis (2013) 1.08
Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans. PLoS One (2013) 1.07
Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status. J Clin Microbiol (2002) 1.02
Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoS One (2011) 1.00
A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin Diagn Lab Immunol (2005) 0.99
Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin Infect Dis (2012) 0.98
Erythromycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother (2002) 0.98
Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States. Clin Infect Dis (2009) 0.94
Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice. Antimicrob Agents Chemother (2002) 0.94
A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis (2013) 0.93
Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis (2011) 0.92
Oral doxycycline for neuroborreliosis. Lancet Neurol (2008) 0.92
CTX-M β-lactamase-producing Klebsiella pneumoniae in suburban New York City, New York, USA. Emerg Infect Dis (2013) 0.91
Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease. Clin Diagn Lab Immunol (2005) 0.89
Hepatitis in association with rickettsialpox. Vector Borne Zoonotic Dis (2008) 0.89
Vertical transmission of Babesia microti, United States. Emerg Infect Dis (2012) 0.88
Recognition and treatment of erythema migrans: are we off target? Ann Intern Med (2002) 0.88
Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. J Clin Microbiol (2012) 0.87
Review: unraveling Lyme disease. Arthritis Rheumatol (2014) 0.87
Response to meta-analysis of Lyme borreliosis symptoms. Int J Epidemiol (2005) 0.87
Potential role of deer tick virus in Powassan encephalitis cases in Lyme disease-endemic areas of New York, U.S.A. Emerg Infect Dis (2013) 0.85
Diagnosis of acute deer tick virus encephalitis. Clin Infect Dis (2012) 0.84
Serologic evaluation of patients from Missouri with erythema migrans-like skin lesions with the C6 Lyme test. Clin Vaccine Immunol (2006) 0.84
Changing epidemiology of Powassan encephalitis in North America suggests the emergence of the deer tick virus subtype. Expert Rev Anti Infect Ther (2013) 0.84
Bacterial contamination of ophthalmic solutions used in an extended care facility. Br J Ophthalmol (2007) 0.84
Evaluation of dedicated stethoscopes as a potential source of nosocomial pathogens. Am J Infect Control (2002) 0.83
Pharmacodynamics of doxycycline for chemoprophylaxis of Lyme disease: preliminary findings and possible implications for other antimicrobials. Int J Antimicrob Agents (2008) 0.83
Lyme disease: diagnostic issues and controversies. Expert Rev Mol Diagn (2014) 0.83
Borrelia burgdorferi spirochetes that harbor only a portion of the lp28-1 plasmid elicit antibody responses detectable with the C6 test for Lyme disease. Clin Vaccine Immunol (2006) 0.83
Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits. J Neuroimmunol (2012) 0.83
Nosocomial transmission of human granulocytic anaplasmosis? JAMA (2008) 0.83
Factors influencing the utilization of Lyme disease-prevention behaviors in a high-risk population. J Am Acad Nurse Pract (2004) 0.82
Evidence for strain-specific immunity in patients treated for early lyme disease. Infect Immun (2014) 0.82
Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis. PLoS One (2013) 0.82
Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay. Transfusion (2014) 0.82
Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism. J Med Ethics (2010) 0.81
Epidemiology of an outbreak of antibiotic-resistant Klebsiella pneumoniae at a tertiary care medical center. Am J Infect Control (2009) 0.79
Accuracy of Diagnosis of Human Granulocytic Anaplasmosis in China. Emerg Infect Dis (2016) 0.78
Non-surgical management of spontaneous splenic rupture due to Babesia microti infection. Ticks Tick Borne Dis (2011) 0.78
Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion. J Infect Dis (2007) 0.78
The Toll of a TLR1 polymorphism in lyme disease: a tale of mice and men. Arthritis Rheum (2012) 0.77
Toward a better understanding of European lyme neuroborreliosis. Clin Infect Dis (2013) 0.77
Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera. Clin Diagn Lab Immunol (2005) 0.76
The reply. Am J Med (2013) 0.75
IFNgamma production in peripheral blood of early Lyme disease patients to hLFAalphaL (aa326-345). BMC Musculoskelet Disord (2002) 0.75
Reinfection versus relapse in Lyme disease. N Engl J Med (2013) 0.75
Advances in the treatment and prevention of Lyme borreliosis. Wien Klin Wochenschr (2005) 0.75
Correction: Lyme borreliosis. Nat Rev Dis Prim (2017) 0.75
A skin lesion in a patient from Kentucky. Clin Infect Dis (2005) 0.75
Impressions of the IX Conference on Lyme Borreliosis and Other Tick-Borne Diseases, August 18-22, 2002. Vector Borne Zoonotic Dis (2002) 0.75